Gene Symbol | Gene ID | Gene Info |
---|---|---|
IRF7
|
ENSG00000185507.15 | interferon regulatory factor 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_612909_613060 | IRF7 | 2642 | 0.119978 | -0.49 | 1.8e-01 | Click! |
chr11_615175_615598 | IRF7 | 240 | 0.825669 | -0.41 | 2.8e-01 | Click! |
chr11_614285_614786 | IRF7 | 1091 | 0.280942 | -0.40 | 2.9e-01 | Click! |
chr11_614044_614195 | IRF7 | 1507 | 0.197318 | -0.40 | 2.9e-01 | Click! |
chr11_616483_616687 | IRF7 | 586 | 0.523899 | -0.39 | 2.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_62485533_62485684 | 0.49 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
7640 |
0.29 |
chr8_22319793_22319944 | 0.45 |
PPP3CC |
protein phosphatase 3, catalytic subunit, gamma isozyme |
13237 |
0.15 |
chrX_30849441_30849592 | 0.44 |
TAB3-AS1 |
TAB3 antisense RNA 1 |
3224 |
0.24 |
chr2_7590065_7590353 | 0.42 |
ENSG00000221255 |
. |
126763 |
0.06 |
chr1_3807784_3807950 | 0.42 |
ENSG00000264428 |
. |
7239 |
0.16 |
chr16_89486895_89487046 | 0.41 |
RP1-168P16.1 |
|
1664 |
0.28 |
chr14_77249034_77249359 | 0.40 |
RP11-488C13.6 |
|
1335 |
0.4 |
chr4_47829536_47829942 | 0.40 |
CORIN |
corin, serine peptidase |
10227 |
0.21 |
chr5_39212456_39212665 | 0.39 |
FYB |
FYN binding protein |
7105 |
0.3 |
chr1_78506342_78506493 | 0.38 |
GIPC2 |
GIPC PDZ domain containing family, member 2 |
5169 |
0.18 |
chr2_222420598_222420749 | 0.38 |
EPHA4 |
EPH receptor A4 |
13528 |
0.21 |
chr6_90919138_90919289 | 0.37 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
87248 |
0.09 |
chr15_22460371_22460742 | 0.36 |
AC010760.1 |
|
3661 |
0.15 |
chr1_226915533_226915684 | 0.35 |
ITPKB |
inositol-trisphosphate 3-kinase B |
9551 |
0.23 |
chr7_138747161_138747312 | 0.35 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
16777 |
0.19 |
chr1_46528401_46528573 | 0.34 |
RP4-533D7.4 |
|
15997 |
0.19 |
chr2_221511090_221511465 | 0.34 |
ENSG00000222096 |
. |
169464 |
0.04 |
chr1_84631383_84631693 | 0.34 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
889 |
0.71 |
chr13_40397431_40397658 | 0.34 |
ENSG00000212553 |
. |
33820 |
0.19 |
chr6_24894743_24895047 | 0.34 |
FAM65B |
family with sequence similarity 65, member B |
16300 |
0.2 |
chr5_94959224_94959533 | 0.33 |
GPR150 |
G protein-coupled receptor 150 |
3596 |
0.22 |
chr6_79779968_79780119 | 0.33 |
PHIP |
pleckstrin homology domain interacting protein |
7910 |
0.3 |
chr7_142420927_142421220 | 0.33 |
PRSS1 |
protease, serine, 1 (trypsin 1) |
36246 |
0.15 |
chr5_49624700_49624851 | 0.33 |
EMB |
embigin |
99786 |
0.09 |
chr5_14707723_14707985 | 0.33 |
FAM105B |
family with sequence similarity 105, member B |
26195 |
0.18 |
chr10_24911730_24912041 | 0.33 |
ARHGAP21 |
Rho GTPase activating protein 21 |
122 |
0.97 |
chr12_112430467_112430685 | 0.33 |
TMEM116 |
transmembrane protein 116 |
13213 |
0.16 |
chr4_102339739_102340117 | 0.33 |
BANK1 |
B-cell scaffold protein with ankyrin repeats 1 |
1190 |
0.58 |
chr1_210513819_210514027 | 0.32 |
HHAT |
hedgehog acyltransferase |
11279 |
0.24 |
chr6_112069105_112069276 | 0.31 |
FYN |
FYN oncogene related to SRC, FGR, YES |
11127 |
0.26 |
chr12_113699598_113700042 | 0.31 |
TPCN1 |
two pore segment channel 1 |
1713 |
0.31 |
chr7_37381820_37382186 | 0.31 |
ELMO1 |
engulfment and cell motility 1 |
364 |
0.89 |
chr1_243517987_243518270 | 0.31 |
ENSG00000265201 |
. |
8650 |
0.26 |
chr10_126628223_126628374 | 0.31 |
ZRANB1 |
zinc finger, RAN-binding domain containing 1 |
2394 |
0.26 |
chr8_29945094_29945295 | 0.31 |
TMEM66 |
transmembrane protein 66 |
4471 |
0.16 |
chr13_41186364_41186802 | 0.31 |
FOXO1 |
forkhead box O1 |
54151 |
0.14 |
chr10_27312984_27313135 | 0.31 |
ANKRD26 |
ankyrin repeat domain 26 |
9451 |
0.23 |
chr16_85137134_85137337 | 0.30 |
FAM92B |
family with sequence similarity 92, member B |
8879 |
0.21 |
chr5_32280871_32281022 | 0.30 |
ENSG00000207052 |
. |
28822 |
0.15 |
chr14_22520830_22521052 | 0.30 |
ENSG00000238634 |
. |
89946 |
0.09 |
chr1_168391686_168391980 | 0.30 |
ENSG00000207974 |
. |
47071 |
0.16 |
chr2_137039834_137039985 | 0.30 |
ENSG00000251976 |
. |
107993 |
0.07 |
chr2_36472218_36472369 | 0.30 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
110776 |
0.07 |
chr5_54871894_54872045 | 0.30 |
PPAP2A |
phosphatidic acid phosphatase type 2A |
41091 |
0.16 |
chr8_71132477_71132643 | 0.29 |
NCOA2 |
nuclear receptor coactivator 2 |
25050 |
0.23 |
chrX_70858439_70858590 | 0.29 |
ENSG00000264855 |
. |
12809 |
0.19 |
chr7_127496048_127496199 | 0.29 |
SND1 |
staphylococcal nuclease and tudor domain containing 1 |
31842 |
0.22 |
chr12_8796592_8796884 | 0.29 |
MFAP5 |
microfibrillar associated protein 5 |
6412 |
0.15 |
chr10_8286398_8286634 | 0.29 |
GATA3 |
GATA binding protein 3 |
189747 |
0.03 |
chrX_131176275_131176426 | 0.29 |
MST4 |
Serine/threonine-protein kinase MST4 |
18714 |
0.21 |
chr14_20950095_20950246 | 0.29 |
PNP |
purine nucleoside phosphorylase |
11485 |
0.09 |
chr21_32531106_32531735 | 0.29 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
28881 |
0.23 |
chr15_81075671_81075822 | 0.29 |
KIAA1199 |
KIAA1199 |
4034 |
0.27 |
chr12_92579451_92579773 | 0.29 |
ENSG00000199895 |
. |
15383 |
0.19 |
chr5_158838364_158838658 | 0.29 |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
80616 |
0.09 |
chr3_107788734_107788929 | 0.28 |
CD47 |
CD47 molecule |
10452 |
0.3 |
chr10_17471175_17471536 | 0.28 |
ST8SIA6-AS1 |
ST8SIA6 antisense RNA 1 |
21329 |
0.17 |
chr1_116013920_116014071 | 0.28 |
ENSG00000265534 |
. |
14277 |
0.26 |
chr18_52384635_52384905 | 0.28 |
RAB27B |
RAB27B, member RAS oncogene family |
321 |
0.94 |
chr16_50815719_50815971 | 0.28 |
CYLD |
cylindromatosis (turban tumor syndrome) |
11683 |
0.13 |
chr3_112644879_112645030 | 0.28 |
CD200R1 |
CD200 receptor 1 |
48805 |
0.11 |
chr6_35278431_35279308 | 0.28 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1354 |
0.42 |
chr18_9134459_9134610 | 0.28 |
RP11-143J12.2 |
|
1114 |
0.39 |
chr22_40448857_40449008 | 0.28 |
TNRC6B |
trinucleotide repeat containing 6B |
7454 |
0.19 |
chr6_20680920_20681105 | 0.28 |
RP3-348I23.2 |
|
119913 |
0.06 |
chr2_202104224_202104480 | 0.27 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
6123 |
0.2 |
chr17_46928469_46928620 | 0.27 |
CALCOCO2 |
calcium binding and coiled-coil domain 2 |
1779 |
0.24 |
chr18_23808202_23808446 | 0.27 |
TAF4B |
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa |
1874 |
0.39 |
chr1_90095113_90095264 | 0.27 |
RP11-413E1.4 |
|
96 |
0.96 |
chr6_36022024_36022175 | 0.27 |
MAPK14 |
mitogen-activated protein kinase 14 |
25233 |
0.16 |
chr1_52888786_52889059 | 0.27 |
ZCCHC11 |
zinc finger, CCHC domain containing 11 |
7831 |
0.14 |
chr1_179111025_179111189 | 0.27 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
1072 |
0.55 |
chr14_75741894_75742142 | 0.27 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
3459 |
0.19 |
chr2_43793678_43793972 | 0.27 |
THADA |
thyroid adenoma associated |
3829 |
0.29 |
chr20_8132706_8132867 | 0.27 |
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
19484 |
0.25 |
chr11_59535226_59535396 | 0.27 |
STX3 |
syntaxin 3 |
12386 |
0.14 |
chr6_112339019_112339170 | 0.27 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
36181 |
0.17 |
chr15_29285508_29285659 | 0.27 |
APBA2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
2961 |
0.31 |
chr15_44963137_44963303 | 0.27 |
PATL2 |
protein associated with topoisomerase II homolog 2 (yeast) |
2537 |
0.22 |
chr2_233942870_233943259 | 0.27 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
17875 |
0.18 |
chr14_50091090_50091241 | 0.27 |
RP11-649E7.5 |
|
967 |
0.31 |
chr12_12165065_12165501 | 0.27 |
BCL2L14 |
BCL2-like 14 (apoptosis facilitator) |
37495 |
0.2 |
chr20_23603657_23603876 | 0.27 |
CST3 |
cystatin C |
14816 |
0.16 |
chr10_104006886_104007037 | 0.26 |
GBF1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1 |
1672 |
0.28 |
chr14_92466123_92466310 | 0.26 |
TRIP11 |
thyroid hormone receptor interactor 11 |
15879 |
0.18 |
chr18_67556534_67556685 | 0.26 |
CD226 |
CD226 molecule |
58046 |
0.15 |
chr6_157293950_157294101 | 0.26 |
ARID1B |
AT rich interactive domain 1B (SWI1-like) |
71518 |
0.13 |
chr4_78514206_78514375 | 0.26 |
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
81383 |
0.1 |
chr4_57251327_57251478 | 0.26 |
AASDH |
aminoadipate-semialdehyde dehydrogenase |
2187 |
0.26 |
chr6_128392441_128392592 | 0.26 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
6608 |
0.28 |
chr6_56753269_56753420 | 0.26 |
DST |
dystonin |
36595 |
0.15 |
chr7_37404005_37404156 | 0.26 |
ELMO1 |
engulfment and cell motility 1 |
10808 |
0.2 |
chr12_21797443_21797594 | 0.26 |
LDHB |
lactate dehydrogenase B |
12778 |
0.18 |
chr1_174846351_174846502 | 0.26 |
RABGAP1L |
RAB GTPase activating protein 1-like |
152 |
0.96 |
chr18_68327050_68327270 | 0.26 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
9180 |
0.32 |
chr3_190163992_190164143 | 0.26 |
TMEM207 |
transmembrane protein 207 |
3598 |
0.3 |
chr8_77908172_77908323 | 0.26 |
PEX2 |
peroxisomal biogenesis factor 2 |
4215 |
0.3 |
chr5_79447122_79447273 | 0.26 |
CTC-458I2.2 |
|
23013 |
0.19 |
chr1_101587391_101587816 | 0.26 |
ENSG00000252765 |
. |
11106 |
0.2 |
chr5_141506960_141507157 | 0.26 |
NDFIP1 |
Nedd4 family interacting protein 1 |
18988 |
0.23 |
chr9_77748055_77748206 | 0.26 |
OSTF1 |
osteoclast stimulating factor 1 |
44671 |
0.12 |
chr12_9819965_9820194 | 0.25 |
CLEC2D |
C-type lectin domain family 2, member D |
2230 |
0.2 |
chr2_173311272_173311492 | 0.25 |
AC078883.4 |
|
18051 |
0.16 |
chr20_31550936_31551087 | 0.25 |
EFCAB8 |
EF-hand calcium binding domain 8 |
3360 |
0.22 |
chr3_151922708_151922859 | 0.25 |
MBNL1 |
muscleblind-like splicing regulator 1 |
63046 |
0.13 |
chr8_22395996_22396147 | 0.25 |
RP11-582J16.4 |
|
6847 |
0.12 |
chr8_59997705_59997856 | 0.25 |
RP11-25K19.1 |
|
33819 |
0.16 |
chr9_112732681_112732832 | 0.25 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
78122 |
0.1 |
chr6_112089861_112090078 | 0.25 |
FYN |
FYN oncogene related to SRC, FGR, YES |
8849 |
0.28 |
chrX_135724911_135725077 | 0.25 |
ENSG00000233093 |
. |
3168 |
0.22 |
chr5_43015531_43015857 | 0.25 |
CTD-2035E11.3 |
|
2837 |
0.21 |
chr16_50310797_50310948 | 0.25 |
ADCY7 |
adenylate cyclase 7 |
2566 |
0.29 |
chr15_25657849_25658000 | 0.25 |
UBE3A |
ubiquitin protein ligase E3A |
4129 |
0.15 |
chr5_169820347_169820594 | 0.25 |
KCNMB1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
3789 |
0.22 |
chr12_92949909_92950139 | 0.24 |
ENSG00000238865 |
. |
11261 |
0.26 |
chr1_214483462_214483613 | 0.24 |
SMYD2 |
SET and MYND domain containing 2 |
20783 |
0.24 |
chr18_74863406_74863557 | 0.24 |
MBP |
myelin basic protein |
18681 |
0.27 |
chr2_218458844_218459122 | 0.24 |
DIRC3 |
disrupted in renal carcinoma 3 |
162295 |
0.04 |
chr7_96466534_96466857 | 0.24 |
ENSG00000244318 |
. |
102981 |
0.07 |
chr5_80302145_80302296 | 0.24 |
CTC-459I6.1 |
|
45494 |
0.15 |
chr3_136636143_136636557 | 0.24 |
NCK1 |
NCK adaptor protein 1 |
10531 |
0.19 |
chr1_25995461_25995725 | 0.24 |
RP1-187B23.1 |
|
9991 |
0.19 |
chr2_65352077_65352228 | 0.24 |
RAB1A |
RAB1A, member RAS oncogene family |
5083 |
0.22 |
chr10_7088660_7089557 | 0.24 |
SFMBT2 |
Scm-like with four mbt domains 2 |
361599 |
0.01 |
chr12_92796935_92797431 | 0.24 |
RP11-693J15.4 |
|
18124 |
0.18 |
chr12_124422307_124422553 | 0.24 |
RP11-380L11.3 |
|
1677 |
0.17 |
chr2_190239203_190239436 | 0.24 |
ENSG00000266817 |
. |
62832 |
0.12 |
chr5_50030005_50030180 | 0.24 |
PARP8 |
poly (ADP-ribose) polymerase family, member 8 |
66701 |
0.15 |
chr13_36907252_36907436 | 0.24 |
SPG20 |
spastic paraplegia 20 (Troyer syndrome) |
13076 |
0.13 |
chr12_92425801_92426181 | 0.24 |
C12orf79 |
chromosome 12 open reading frame 79 |
104806 |
0.07 |
chr10_76633934_76634174 | 0.24 |
KAT6B |
K(lysine) acetyltransferase 6B |
35596 |
0.21 |
chr12_21831996_21832380 | 0.24 |
RP11-59N23.3 |
|
16941 |
0.18 |
chr11_104519828_104519979 | 0.24 |
CASP12 |
caspase 12 (gene/pseudogene) |
249238 |
0.02 |
chr7_8181558_8181709 | 0.24 |
ENSG00000265212 |
. |
13019 |
0.21 |
chr3_180651200_180651351 | 0.24 |
FXR1 |
fragile X mental retardation, autosomal homolog 1 |
18027 |
0.21 |
chr7_38348883_38349236 | 0.24 |
STARD3NL |
STARD3 N-terminal like |
131062 |
0.05 |
chr9_77766078_77766231 | 0.24 |
ENSG00000200041 |
. |
30383 |
0.16 |
chr7_81514083_81514336 | 0.24 |
ENSG00000263416 |
. |
35377 |
0.21 |
chr1_205595237_205595704 | 0.24 |
ELK4 |
ELK4, ETS-domain protein (SRF accessory protein 1) |
5620 |
0.17 |
chr7_37403219_37403780 | 0.24 |
ELMO1 |
engulfment and cell motility 1 |
10227 |
0.2 |
chr1_121348654_121348844 | 0.24 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
412812 |
0.01 |
chr11_121162107_121162258 | 0.24 |
SC5D |
sterol-C5-desaturase |
980 |
0.7 |
chr6_49519591_49519742 | 0.24 |
C6orf141 |
chromosome 6 open reading frame 141 |
1553 |
0.44 |
chr9_13377222_13377373 | 0.24 |
MPDZ |
multiple PDZ domain protein |
97708 |
0.08 |
chrX_40140473_40140823 | 0.24 |
ENSG00000238920 |
. |
3701 |
0.36 |
chr15_38958428_38958579 | 0.24 |
C15orf53 |
chromosome 15 open reading frame 53 |
30296 |
0.22 |
chr1_92789162_92789478 | 0.24 |
GLMN |
glomulin, FKBP associated protein |
24776 |
0.17 |
chr3_156201288_156201439 | 0.24 |
KCNAB1-AS1 |
KCNAB1 antisense RNA 1 |
36669 |
0.17 |
chr19_50407502_50407838 | 0.24 |
IL4I1 |
interleukin 4 induced 1 |
7458 |
0.06 |
chr14_52331443_52331710 | 0.24 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
3534 |
0.26 |
chr1_11028360_11028511 | 0.24 |
C1orf127 |
chromosome 1 open reading frame 127 |
4177 |
0.17 |
chr12_15715155_15715553 | 0.24 |
PTPRO |
protein tyrosine phosphatase, receptor type, O |
16068 |
0.26 |
chrX_78519115_78519266 | 0.24 |
GPR174 |
G protein-coupled receptor 174 |
92721 |
0.09 |
chrX_123138511_123138662 | 0.24 |
STAG2 |
stromal antigen 2 |
41566 |
0.17 |
chr2_197046557_197046870 | 0.24 |
STK17B |
serine/threonine kinase 17b |
5486 |
0.21 |
chr9_139135589_139135794 | 0.24 |
QSOX2 |
quiescin Q6 sulfhydryl oxidase 2 |
1996 |
0.31 |
chr3_108021242_108021538 | 0.24 |
HHLA2 |
HERV-H LTR-associating 2 |
58 |
0.98 |
chr8_133533629_133533893 | 0.23 |
KCNQ3 |
potassium voltage-gated channel, KQT-like subfamily, member 3 |
40561 |
0.19 |
chr1_220414638_220414789 | 0.23 |
RAB3GAP2 |
RAB3 GTPase activating protein subunit 2 (non-catalytic) |
29994 |
0.17 |
chr2_26016237_26016499 | 0.23 |
ASXL2 |
additional sex combs like 2 (Drosophila) |
13190 |
0.24 |
chr2_196446250_196446401 | 0.23 |
SLC39A10 |
solute carrier family 39 (zinc transporter), member 10 |
5624 |
0.29 |
chr12_9104317_9104548 | 0.23 |
KLRG1 |
killer cell lectin-like receptor subfamily G, member 1 |
1792 |
0.26 |
chr13_30852418_30852661 | 0.23 |
ENSG00000252928 |
. |
3363 |
0.3 |
chr1_151427104_151427255 | 0.23 |
POGZ |
pogo transposable element with ZNF domain |
354 |
0.81 |
chr2_169032889_169033150 | 0.23 |
STK39 |
serine threonine kinase 39 |
71632 |
0.13 |
chr12_96537632_96537783 | 0.23 |
ENSG00000266889 |
. |
41680 |
0.13 |
chr9_90323622_90323773 | 0.23 |
CTSL |
cathepsin L |
16737 |
0.2 |
chr6_157420488_157420639 | 0.23 |
RP1-137K2.2 |
|
20277 |
0.25 |
chr6_112157210_112157486 | 0.23 |
FYN |
FYN oncogene related to SRC, FGR, YES |
8799 |
0.29 |
chr20_13210302_13210453 | 0.23 |
ISM1 |
isthmin 1, angiogenesis inhibitor |
7959 |
0.2 |
chr6_142716433_142716768 | 0.23 |
GPR126 |
G protein-coupled receptor 126 |
5151 |
0.33 |
chr13_74625480_74625801 | 0.23 |
KLF12 |
Kruppel-like factor 12 |
56454 |
0.17 |
chr1_226178883_226179034 | 0.23 |
SDE2 |
SDE2 telomere maintenance homolog (S. pombe) |
8074 |
0.16 |
chr22_40513966_40514117 | 0.23 |
TNRC6B |
trinucleotide repeat containing 6B |
59888 |
0.12 |
chr3_118945056_118945207 | 0.23 |
B4GALT4-AS1 |
B4GALT4 antisense RNA 1 |
202 |
0.93 |
chr17_76815501_76815673 | 0.23 |
USP36 |
ubiquitin specific peptidase 36 |
3744 |
0.21 |
chr1_249110651_249111042 | 0.23 |
SH3BP5L |
SH3-binding domain protein 5-like |
426 |
0.79 |
chr4_40207228_40207547 | 0.23 |
RHOH |
ras homolog family member H |
5423 |
0.24 |
chr15_75897408_75897633 | 0.23 |
SNUPN |
snurportin 1 |
12345 |
0.11 |
chr3_190025299_190025450 | 0.23 |
CLDN1 |
claudin 1 |
14890 |
0.24 |
chr19_47649979_47650273 | 0.23 |
SAE1 |
SUMO1 activating enzyme subunit 1 |
15974 |
0.15 |
chr17_73080067_73080518 | 0.23 |
SLC16A5 |
solute carrier family 16 (monocarboxylate transporter), member 5 |
3530 |
0.11 |
chr7_132120161_132120457 | 0.23 |
AC011625.1 |
|
83216 |
0.1 |
chr6_28490581_28490732 | 0.23 |
GPX5 |
glutathione peroxidase 5 (epididymal androgen-related protein) |
3046 |
0.23 |
chr5_35803659_35803974 | 0.23 |
CTD-2113L7.1 |
|
23304 |
0.17 |
chr8_129297025_129297176 | 0.23 |
ENSG00000201782 |
. |
64350 |
0.14 |
chr17_79603290_79603590 | 0.23 |
NPLOC4 |
nuclear protein localization 4 homolog (S. cerevisiae) |
646 |
0.5 |
chr7_144468170_144468428 | 0.23 |
TPK1 |
thiamin pyrophosphokinase 1 |
32284 |
0.22 |
chr8_42035186_42035337 | 0.22 |
AP3M2 |
adaptor-related protein complex 3, mu 2 subunit |
10454 |
0.15 |
chr12_48593391_48593547 | 0.22 |
DKFZP779L1853 |
|
1299 |
0.34 |
chr14_106560956_106561107 | 0.22 |
IGHV2-10 |
immunoglobulin heavy variable 2-10 (pseudogene) |
1056 |
0.2 |
chr12_28763600_28763751 | 0.22 |
CCDC91 |
coiled-coil domain containing 91 |
61678 |
0.15 |
chr3_23695229_23695380 | 0.22 |
ENSG00000212269 |
. |
12221 |
0.23 |
chr12_10446475_10446699 | 0.22 |
KLRD1 |
killer cell lectin-like receptor subfamily D, member 1 |
10458 |
0.17 |
chr3_150423257_150423408 | 0.22 |
RP11-103G8.2 |
|
1502 |
0.31 |
chr6_35590292_35590577 | 0.22 |
ENSG00000212579 |
. |
29161 |
0.14 |
chr2_119599709_119600100 | 0.22 |
EN1 |
engrailed homeobox 1 |
5350 |
0.31 |
chr2_120802121_120802311 | 0.22 |
EPB41L5 |
erythrocyte membrane protein band 4.1 like 5 |
25555 |
0.22 |
chr5_14811591_14811796 | 0.22 |
ENSG00000264792 |
. |
14428 |
0.24 |
chr6_44890627_44890778 | 0.22 |
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
32545 |
0.25 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.5 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.3 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.3 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.7 | GO:0002837 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.3 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.4 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.3 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 2.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.5 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.1 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.3 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.4 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.2 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.2 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.0 | 0.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:1904063 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.3 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.1 | GO:0014034 | neural crest formation(GO:0014029) neural crest cell fate commitment(GO:0014034) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.0 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.0 | GO:0098900 | regulation of action potential(GO:0098900) |
0.0 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.0 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.0 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.3 | GO:0090278 | negative regulation of peptide hormone secretion(GO:0090278) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.9 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.0 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.0 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.0 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.0 | 0.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.1 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.0 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.4 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.0 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.0 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.0 | GO:1903313 | regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.1 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.2 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.0 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
0.0 | 0.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.0 | GO:0072179 | nephric duct formation(GO:0072179) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.0 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:2001257 | regulation of calcium ion transmembrane transporter activity(GO:1901019) regulation of cation channel activity(GO:2001257) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.2 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.3 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.0 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 1.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.6 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.2 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 2.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.7 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.7 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 1.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.2 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 1.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.0 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.0 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.4 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.0 | GO:0004064 | arylesterase activity(GO:0004064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 1.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.9 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |